Edap tms sa- adr EDAP.US Overview Analysis
EDAP AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
EDAP Current Performance
1.23%
Edap tms sa- adr
0.77%
Avg of Sector
0.24%
S&P500
Top 10 High Relevance to EDAP
| Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
|---|---|---|---|---|---|---|---|
AHCO | Adapthealth corp | 4 | 1 | 3 | 4 | 1 | |
ZIMV | Zimvie inc | - | 3 | 5 | 2 | 1 | |
BNR | Burning rock biotech ltd - adr | 2 | 4 | 4 | - | 1 |
- AHCO Adapthealth corpValue 4Trend 1Swing Trading 3Whale Interest 4Dividend 1See more
EDAP Profile
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners